Cargando…
Epigenetic silencing of RASSF1A deregulates cytoskeleton and promotes malignant behavior of adrenocortical carcinoma
BACKGROUND: Adrenocortical carcinoma (ACC) is a rare endocrine malignancy with high mutational heterogeneity and a generally poor clinical outcome. Despite implicated roles of deregulated TP53, IGF-2 and Wnt signaling pathways, a clear genetic association or unique mutational link to the disease is...
Autores principales: | Korah, Reju, Healy, James M, Kunstman, John W, Fonseca, Annabelle L, Ameri, Amir H, Prasad, Manju L, Carling, Tobias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3750604/ https://www.ncbi.nlm.nih.gov/pubmed/23915220 http://dx.doi.org/10.1186/1476-4598-12-87 |
Ejemplares similares
-
Gene Expression and Regulation in Adrenocortical Tumorigenesis
por: Fonseca, Annabelle L., et al.
Publicado: (2012) -
Whole-Exome Sequencing of Syndromic Adrenocortical Carcinoma Reveals Distinct Mutational Profile From Sporadic ACC
por: Nicolson, Norman G, et al.
Publicado: (2019) -
Adrenocortical Carcinoma: Current Therapeutic State-of-the-Art
por: Lebastchi, Amir H., et al.
Publicado: (2012) -
A novel FOXO1-mediated dedifferentiation blocking role for DKK3 in adrenocortical carcinogenesis
por: Cheng, Joyce Y., et al.
Publicado: (2017) -
SLC12A7 alters adrenocortical carcinoma cell adhesion properties to promote an aggressive invasive behavior
por: Brown, Taylor C., et al.
Publicado: (2018)